Unknown

Dataset Information

Vasoconstrictor antagonism improves functional and structural vascular alterations and liver damage in rats with early NAFLD.


ABSTRACT:

Background & aims

Intrahepatic vascular resistance is increased in early non-alcoholic fatty liver disease (NAFLD), potentially leading to tissue hypoxia and triggering disease progression. Hepatic vascular hyperreactivity to vasoconstrictors has been identified as an underlying mechanism. This study investigates vasoconstrictive agonism and antagonism in 2 models of early NAFLD and in non-alcoholic steatohepatitis (NASH).

Methods

The effects of endothelin-1 (ET-1), angiotensin II (ATII) and thromboxane A2 (TxA2) agonism and antagonism were studied by in situ ex vivo liver perfusion and preventive/therapeutic treatment experiments in a methionine-choline-deficient diet model of steatosis. Furthermore, important results were validated in Zucker fa

SUBMITTER: van der Graaff D 

PROVIDER: S-EPMC8749167 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature